Darou Pakhsh
Company type | TPICO (74.5%)[1] |
---|---|
Website | www.dpholding.com |
Darou Pakhsh Holding Company (
Social Security Organization of Iran. The company manufactures, distributes, imports and exports finished products and pharmaceutical raw materials. Darou Pakhsh has an annual turnover of US$400m and claims to have the largest research and development operation of any Iranian drug firm.[2] The company formed a plasmapheresis joint venture with a German medical firm, Biotest AG, in early 2004.[2] Darou Pakhsh is listed on the Tehran Stock Exchange
.
History
Initially, the plant had been designed to produce 20 dosage forms.
See also
References
- ^ "Daroupakhsh ( DARO1 ) info". tsetmc.com. Retrieved 2012-05-26.
- ^ a b IRAN: Healthcare and Pharmaceuticals Forecast, Economist Intelligence Unit, August 18, 2008